Cargando…
One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection
Monogenic disorders (MGDs), which are caused by single gene mutations, have a serious effect on human health. Among these, β-thalassemia (β-thal) represents one of the most common hereditary hematological diseases caused by mutations in the human hemoglobin β (HBB) gene. The technologies of induced...
Autores principales: | Liu, Yali, Yang, Yi, Kang, Xiangjin, Lin, Bin, Yu, Qian, Song, Bing, Gao, Ge, Chen, Yaoyong, Sun, Xiaofang, Li, Xiaoping, Bu, Lei, Fan, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363452/ https://www.ncbi.nlm.nih.gov/pubmed/28325300 http://dx.doi.org/10.1016/j.omtn.2016.11.010 |
Ejemplares similares
-
Microhomology-assisted scarless genome editing in human iPSCs
por: Kim, Shin-Il, et al.
Publicado: (2018) -
Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
por: Yang, Yi, et al.
Publicado: (2018) -
One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
por: Wattanapanitch, Methichit, et al.
Publicado: (2018) -
Targeted biallelic integration of an inducible Caspase 9 suicide gene in iPSCs for safer therapies
por: Wunderlich, Stephanie, et al.
Publicado: (2022) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014)